Current state of cannabis use, policies, and research across sixteen countries: cross-country comparisons and international perspectives.

Cannabis global health legalization policies research

Journal

Trends in psychiatry and psychotherapy
ISSN: 2238-0019
Titre abrégé: Trends Psychiatry Psychother
Pays: Brazil
ID NLM: 101610695

Informations de publication

Date de publication:
14 Jul 2022
Historique:
received: 17 03 2021
accepted: 22 10 2021
pubmed: 5 11 2021
medline: 19 7 2022
entrez: 4 11 2021
Statut: epublish

Résumé

Varying public views on cannabis use across countries may explain the variation in the prevalence of use, policies, and research in individual countries, and global regulation of cannabis. This paper aims to describe the current state of cannabis use, policies, and research across sixteen countries. PubMed and Google Scholar were searched for studies published from 2010 to 2020. Searches were conducted using the relevant country of interest as a search term (e.g., "Iran"), as well as relevant predefined keywords such as "cannabis," "marijuana," "hashish," "bhang "dual diagnosis," "use," "addiction," "prevalence," "co-morbidity," "substance use disorder," "legalization" or "policy" (in English and non-English languages). These keywords were used in multiple combinations to create the search string for studies' titles and abstracts. Official websites of respective governments and international organizations were also searched in English and non-English languages (using countries national languages) to identify the current state of cannabis use, policies, and research in each of those countries. The main findings were inconsistent and heterogeneous reporting of cannabis use, variation in policies (e.g., legalization), and variation in intervention strategies across the countries reviewed. European countries dominate the cannabis research output indexed on PubMed, in contrast to Asian countries (Thailand, Malaysia, India, Iran, and Nepal). Although global cannabis regulation is ongoing, the existing heterogeneities across countries in terms of policies and epidemiology can increase the burden of cannabis use disorders disproportionately and unpredictably. There is an urgent need to develop global strategies to address these cross-country barriers to improve early detection, prevention, and interventions for cannabis use and related disorders.

Identifiants

pubmed: 34735077
doi: 10.47626/2237-6089-2021-0263
pmc: PMC9490942
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e20210263

Déclaration de conflit d'intérêts

No conflicts of interest declared concerning the publication of this article.

Références

Lancet. 2019 Oct 26;394(10208):1580-1590
pubmed: 31657733
East Afr Med J. 1994 Feb;71(2):93-7
pubmed: 7925052
Addiction. 2018 Oct;113(10):1905-1926
pubmed: 29749059
Medicina (Kaunas). 2019 Aug 23;55(9):
pubmed: 31450833
Mayo Clin Proc. 2012 Feb;87(2):172-86
pubmed: 22305029
PLoS One. 2015 Oct 13;10(10):e0140005
pubmed: 26461494
Contemp Clin Trials. 2017 Aug;59:1-12
pubmed: 28479216
J Drug Issues. 2018 Jul;48(3):421-434
pubmed: 29899577
Indian J Psychol Med. 2022 May;44(3):285-289
pubmed: 35656417
Tumori. 2020 Aug;106(4):281-285
pubmed: 32178596
Asia Pac J Public Health. 2019 Nov;31(8_suppl):48S-56S
pubmed: 31347375
Schizophr Bull. 2016 Sep;42(5):1262-9
pubmed: 26884547
SAHARA J. 2010 Dec;7(4):10-6
pubmed: 21409306
J Psychoactive Drugs. 2017 Jul-Aug;49(3):217-224
pubmed: 28632077
Int J Mol Sci. 2021 Feb 13;22(4):
pubmed: 33668469
BMC Psychiatry. 2020 Apr 29;20(1):191
pubmed: 32349714
Drug Alcohol Depend. 2007 Apr;88 Suppl 1:S60-70
pubmed: 17257779
BMC Psychiatry. 2018 Sep 27;18(1):314
pubmed: 30261864
Am J Mens Health. 2019 Nov-Dec;13(6):1557988319892464
pubmed: 31795801
New Dir Youth Dev. 2014 Spring;2014(141):67-82, 11-2
pubmed: 24753279
P T. 2017 Mar;42(3):180-188
pubmed: 28250701
Braz J Psychiatry. 2010 May;32 Suppl 1:S56-66
pubmed: 20512271
Psychiatry J. 2018 Feb 19;2018:6731341
pubmed: 29670893
JNMA J Nepal Med Assoc. 2010 Oct-Dec;50(180):267-72
pubmed: 22049888
Pharmaceuticals (Basel). 2021 Jan 13;14(1):
pubmed: 33451073
Indian J Psychiatry. 2020 Jul-Aug;62(4):427-430
pubmed: 33165333
Subst Use Misuse. 2019;54(12):1980-1990
pubmed: 31220980
Reprod Health. 2020 Feb 17;17(1):25
pubmed: 32066469
Andrology. 2021 Mar;9(2):503-510
pubmed: 33251770
Asia Pac Psychiatry. 2021 Mar;13(1):e12432
pubmed: 33145988
J Pain Res. 2020 Feb 14;13:399-410
pubmed: 32104061
Iran J Psychiatry. 2014 Apr;9(2):96-109
pubmed: 25632287
J Med Assoc Thai. 2011 Jan;94(1):110-7
pubmed: 21425736
J Psychoactive Drugs. 1981 Jan-Mar;13(1):23-34
pubmed: 7024492
Health Econ. 2010 Nov;19(11):1281-99
pubmed: 19937639
BMC Psychiatry. 2018 Jun 18;18(1):197
pubmed: 29914409
S Afr Med J. 2009 May;99(5 Pt 2):339-44
pubmed: 19588796
BMC Psychiatry. 2014 May 10;14:136
pubmed: 24884989
Mo Med. 2012 Mar-Apr;109(2):90-8
pubmed: 22675784
Psychiatr Clin North Am. 2001 Sep;24(3):479-96, vii-viii
pubmed: 11593858
Eur Psychiatry. 2019 Feb;56:8-13
pubmed: 30447436
Drug Alcohol Depend. 2014 Mar 1;136:79-84
pubmed: 24438843
JAMA Psychiatry. 2019 Apr 1;76(4):426-434
pubmed: 30758486
BMJ Open. 2019 Nov 11;9(11):e031737
pubmed: 31719086
Drug Alcohol Depend. 2019 Jul 1;200:82-94
pubmed: 31112834
Subst Abus. 2019;40(2):178-184
pubmed: 30883274
Curr Addict Rep. 2017 Jun;4(2):100-109
pubmed: 29062679
Curr Pharm Des. 2016;22(42):6340-6352
pubmed: 27526792
J Neurosci Rural Pract. 2020 Apr;11(2):299-308
pubmed: 32405186
Ind Psychiatry J. 2018 Jul-Dec;27(2):264-270
pubmed: 31359982
Subst Abus. 2010 Jul;31(3):170-3
pubmed: 20687005
F1000Res. 2020 Mar 23;9:201
pubmed: 32789008
PLoS One. 2020 Aug 28;15(8):e0238170
pubmed: 32857791
World Psychiatry. 2020 Jun;19(2):187-188
pubmed: 32394558
Rev Panam Salud Publica. 2008 Jun;23(6):384-93
pubmed: 18644206
Pan Afr Med J. 2014 Jan 18;17 Suppl 1:11
pubmed: 24624244
J Nepal Health Res Counc. 2010 Apr;8(1):15-8
pubmed: 21879007
Am J Mens Health. 2015 Sep;9(5):397-409
pubmed: 25147097
Int J Drug Policy. 2014 Nov;25(6):1103-12
pubmed: 25097092
Asia Pac J Public Health. 2014 Sep;26(5 Suppl):53S-62S
pubmed: 25070697
Addiction. 2016 Oct;111(10):1836-47
pubmed: 27177849
Drug Alcohol Rev. 2018 Jul;37(5):658-663
pubmed: 29488268
Psychiatry Res. 2021 Mar;297:113731
pubmed: 33493730
Indian J Psychiatry. 2020 May-Jun;62(3):235-241
pubmed: 32773864

Auteurs

Ramdas Ransing (R)

Department of Psychiatry, BKL Walawalkar Rural Medical College, Maharashtra, India.

Pedro A de la Rosa (PA)

Educación de la Afectividad y Sexualidad Humana, Instituto Cultura y Sociedad, Universidad de Navarra, Pamplona, Spain. Human Flourishing Program, Institute for Quantitative Social Science, Harvard University, Cambridge, MA, USA.

Victor Pereira-Sanchez (V)

Department of Child and Adolescent Psychiatry, New York University Grossman School of Medicine, New York, NY, USA.

Jibril I M Handuleh (JIM)

Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.

Stefan Jerotic (S)

Clinic for Psychiatry, Clinical Centre of Serbia, Belgrade, Serbia.

Anoop Krishna Gupta (AK)

Department of Psychiatry, National Medical College, Birgunj, Parsa, Nepal.

Ruta Karaliuniene (R)

Elblandklinikum Radebeul Clinic for Psychiatry and Psychotherapy, Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany.

Renato de Filippis (R)

Psychiatry Unit, Department of Health Sciences, University Magna Graecia of Catanzaro, Viale Europa, Catanzaro, Italy.

Eric Peyron (E)

Clinique Belmont, Genève, Switzerland.

Ekin Sönmez Güngör (E)

Department of Psychiatry, University of Health Sciences, Erenköy Mental Health and Neurological Diseases Training and Research Hospital, Istanbul, Turkey.

Said Boujraf (S)

Clinical Neurosciences Laboratory, Sidi Mohamed ben Abdellah University, Fez, Morocco.

Anne Yee (A)

Department of Psychological Medicine, University Malaya Centre of Addiction Sciences, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Bita Vahdani (B)

Qazvin University of Medical Sciences Qazvin, Iran. Department of Psychology, University of Tehran, Tehran, Iran.

Sheikh Shoib (S)

Department of Psychiatry, Jawahar Lal Nehru Memorial Hospital, Rainawari, Kashmir, India.

M J Stowe (MJ)

Department of Family Medicine, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.

Florence Jaguga (F)

Moi Teaching & Referral Hospital, Eldoret, Kenya.

Lisa Dannatt (L)

Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.

Alexandre Kieslich da Silva (AK)

Faculty of Medicine, University of Vale do Taquari, Lajeado, RS, Brazil.

Paolo Grandinetti (P)

Addictions Service, Department of Territorial Services, ASL Teramo, Teramo, Italy.

Chonnakarn Jatchavala (C)

Department of Psychiatry, Faculty of Medicine, Prince of Songkla University, Songkla, Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH